Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806295 · ClinicalTrials.gov registry record
The Leukemia and Lymphoma Society (LLS) National Research Registry
A clinical trial of Blood Cancer, sponsored by Blood Cancer United.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04806295 is a study of Blood Cancer that is actively recruiting participants, run by Blood Cancer United. The registered enrollment target is 1,000 participants, above the 182-participant average among 12 other Blood Cancer trials with a reported enrollment target (449% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04806295, a study of Blood Cancer, is actively recruiting participants, sponsored by Blood Cancer United.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.
Conditions Studied
Interventions
- OTHER any/all treatments for blood cancer
Study Locations (1)
New York
- Lymphoma and Leukemia Society - Rye Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-07-24 |
| Est. Completion | 2027-07-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04806295
The ClinicalTrials.gov registry entry for NCT04806295 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 182-participant average among 12 other Blood Cancer trials with a reported enrollment target (449% higher). The listed sponsor is Blood Cancer United, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Cancer appearing as the primary indexed condition, and to 1 intervention - of which any/all treatments for blood cancer is the first listed.
NCT04806295 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04806295 about?
NCT04806295 is a clinical study titled "The Leukemia and Lymphoma Society (LLS) National Research Registry". The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.
What is the current status of trial NCT04806295?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-07-24. Estimated completion is 2027-07-23.
What conditions does trial NCT04806295 study?
This clinical trial studies the following conditions: Blood Cancer.
What interventions are being tested in trial NCT04806295?
The interventions under investigation include: any/all treatments for blood cancer (OTHER).
Who is sponsoring clinical trial NCT04806295?
This trial is sponsored by Blood Cancer United, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04806295 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
RECRUITING · Phase 1
-
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
RECRUITING · Phase 2
-
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
RECRUITING · NA
-
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
RECRUITING · NA
-
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.